| Primary |
| Vertigo |
44.4% |
| Vomiting |
17.8% |
| Chronic Obstructive Pulmonary Disease |
8.9% |
| Motion Sickness |
8.9% |
| Dizziness |
6.7% |
| Hypertension |
4.4% |
| Nausea |
4.4% |
| Depression |
2.2% |
| Neck Pain |
2.2% |
|
| Torticollis |
17.6% |
| Tremor |
11.8% |
| Depression |
5.9% |
| Dystonia |
5.9% |
| Pain |
5.9% |
| Tongue Oedema |
5.9% |
| Urinary Retention |
5.9% |
| Visual Acuity Reduced |
5.9% |
| Anxiety Disorder |
2.9% |
| Dyskinesia |
2.9% |
| Facial Palsy |
2.9% |
| Grand Mal Convulsion |
2.9% |
| Laryngospasm |
2.9% |
| Oculogyration |
2.9% |
| Somnolence |
2.9% |
| Speech Disorder |
2.9% |
| Tonic Clonic Movements |
2.9% |
| Unresponsive To Stimuli |
2.9% |
| Vertigo |
2.9% |
| Vomiting |
2.9% |
|
| Secondary |
| Drug Use For Unknown Indication |
44.0% |
| Femur Fracture |
23.8% |
| Vertigo |
11.9% |
| Motion Sickness |
7.1% |
| Diarrhoea |
4.8% |
| Nausea |
2.4% |
| Dizziness |
1.2% |
| Neck Pain |
1.2% |
| Sedation |
1.2% |
| Spinal Disorder |
1.2% |
| Upper Respiratory Tract Infection |
1.2% |
|
| Respiratory Failure |
23.8% |
| Visual Acuity Reduced |
19.0% |
| Drug Hypersensitivity |
14.3% |
| Tremor |
9.5% |
| Anxiety Disorder |
4.8% |
| Depression |
4.8% |
| Pain |
4.8% |
| Respiratory Distress |
4.8% |
| Speech Disorder |
4.8% |
| Torticollis |
4.8% |
| Toxicity To Various Agents |
4.8% |
|
| Concomitant |
| Prophylaxis |
18.3% |
| Breast Cancer Metastatic |
15.0% |
| Breast Cancer |
11.3% |
| Neoplasm Malignant |
8.3% |
| Ovarian Cancer |
8.1% |
| Metastases To Bone |
4.4% |
| Discomfort |
4.1% |
| Granulocyte Count Decreased |
4.1% |
| Hot Flush |
4.1% |
| Migraine |
4.1% |
| Non-small Cell Lung Cancer |
3.3% |
| Lung Neoplasm Malignant |
2.7% |
| Pain |
2.5% |
| Gastrooesophageal Reflux Disease |
2.2% |
| Vomiting |
1.6% |
| Diabetes Mellitus |
1.4% |
| Product Used For Unknown Indication |
1.4% |
| Colorectal Cancer |
1.3% |
| Femur Fracture |
1.1% |
| Nausea |
1.1% |
|
| Wound Treatment |
22.5% |
| Vomiting |
20.0% |
| Renal Failure |
7.5% |
| Hypomagnesaemia |
5.0% |
| Hypotonia Neonatal |
5.0% |
| Venous Thrombosis |
5.0% |
| Myocardial Infarction |
3.8% |
| Weight Increased |
3.8% |
| White Blood Cell Count |
3.8% |
| Mobility Decreased |
2.5% |
| Neoplasm Malignant |
2.5% |
| Pancytopenia |
2.5% |
| Pneumonia |
2.5% |
| Respiratory Failure |
2.5% |
| Urinary Tract Infection |
2.5% |
| Vasculitis |
2.5% |
| White Blood Cell Count Decreased |
2.5% |
| Abdominal Pain |
1.3% |
| Arthritis |
1.3% |
| Blood Pressure Decreased |
1.3% |
|
| Interacting |
| Drug Use For Unknown Indication |
60.0% |
| Femur Fracture |
40.0% |
|
| Respiratory Failure |
100.0% |
|
